Jennifer Nickol, DO
Internal Medicine · Tallahassee, FLNPI 1932620895
Payments from drug & device makers
What this record shows
This record is dominated by grants: $18,000 of the $20,762 with a category attached, or 86.7%. Abbott accounts for 96.2% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $18,100, more than ten times the $86 reported in 2019. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $346.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$20K
- Novo Nordisk$128
- Alnylam Pharmaceuticals Inc.$125
- Cardiva Medical, Inc.$122
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$111
- Astellas Pharma US Inc$99
- plus $203 from 9 others
What the payments were for
- Grants$18,00087%
- Travel & lodging$4122%
- Food & beverage$1,6958%
- Education$6553%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 41 | $19,974 |
| Novo Nordisk | 2 | $128 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Cardiva Medical, Inc. | 1 | $122 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $111 |
| Astellas Pharma US Inc | 1 | $99 |
| Abiomed | 3 | $57 |
| Novartis | 1 | $30 |
| Pfizer | 2 | $29 |
| Global Blood Therapeutics, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Bayer | 1 | $15 |
| AbbVie | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,762 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sildenafil Citrate | 14 | $10,449 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tallahassee
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.